Verifying Your Aggregate Spend Program and Transparency Reports
Tuesday, April 30, 2013 from 11:00 AM to Noon EDT
Huron Life Sciences’ Aggregate Spend experts will provide attendees with concrete takeaways to enhance their aggregate spend capture and reporting capabilities through verification tasks to meet the requirements of OpenPayments. Additionally, attendees will be given ideas on next steps in creating their internal auditing and monitoring programs as well as disciplinary action for increased adherence to OpenPayments requirements.
Register Free at http://www.pharmexec.com/aggspend
Huron Life Sciences
Nursing and Adherence
Wednesday, May 8, 2012 from 11AM to Noon EDT
Come learn how nursing services are being utilized by pharmaceutical manufacturers to increase patient education about their therapy and how they interact with prescribers in order to maximize therapy adherence.
Register Free at http://www.pharmexec.com/nursingwebcast
UBC Express Scripts
Retrospective Chart Review Studies: Application of Methodology to Evaluate Burden of Illness, Drug Utilization and Safety
Tuesday, May 14, 2013 from 11AM to Noon EDT
Did you know that chart review studies can be used to gather real world data in support of burden of illness, patterns of care and drug utilization and safety evaluations? Join us to learn more about how chart review studies can help you meet your real-world evidence gathering goals and objectives.
Register Free at http://www.pharmexec.com/burden
UBC Express Scripts
ON-DEMAND WEBCASTS NOW AVAILABLE FOR REPLAY
New models of cancer research in the age of personalized medicine
Recorded on: April 17, 2013
In the age of personalized medicine, an effective patient identification approach coupled with streamlined operational processes is crucial to meeting enrollment goals for clinical trials in oncology. Join Lisa Holland, Senior Director of Clinical Development at US Oncology Research, for a discussion about the key factors that drive successful clinical study start up and execution.
Register Free at http://www.pharmexec.com/personalized
Engage Nurse Practitioners through their Trusted Destination- “Generation NP”
Recorded on: March 26, 2013
Need to reach 40,000+ Nurse Practitioners with prescribing rights immediately? Let us show you how to effectively and efficiently accomplish this goal by utilizing Generation NP.
Register Free at http://www.pharmexec.com/generationnp
Accelerate Your Brand’s Growth With Connectivity Into the Community Pharmacy
Recorded on: March 20, 2013
Pharmaceutical brand teams are faced with a variety of challenges that inhibit their brand’s growth. Join this webinar to learn how the community pharmacy – with its direct access to prescribers and patients – can be a key partner in helping brand teams overcome many of these challenges to invigorate market share growth.
Register Free at http://www.pharmexec.com/community
Leveraging New Pharma Technologies to Improve the Customer Experience
Recorded on: February 27, 2013
Improving the customer experience for any pharma brand will be a top priority in 2013. Leveraging new pharma technologies will not only help you reduce costs but improve customer relationships.
Register Free at http://www.pharmexec.com/experience
Innovative Approaches to Database Study Design and Analysis: Opportunities and Challenges
Recorded on: January 31, 2013
Navigating medical products successfully to market and beyond is highly complex – compounded by the fact that understanding the needs and criteria of stakeholders (whether Regulatory, Payer, Patient or Prescriber) often requires substantial effort and strategic thinking. Anticipating stakeholder needs for effective planning allows for evidence to be produced that will be of value to stakeholders. With the changing Regulatory and Payer environment ,what are the implications for database study design and analysis in the future?
This webinar explores these issues, highlighting opportunities, challenges, presenting real world examples and providing practical guidance.
Register Free at http://www.pharmexec.com/approaches
Liberating Mobile Technology
Recorded on: January 23, 2013
- Mobile technology’s role in aligning GPs and sales representatives in the fight against the disease or condition.
- How interactive dialogue can be tailored to each physician's needs for richer, pull driven conversations.
- Understanding the closed loop analytics platform, an enabler for knowledge transfer and dialogue.
Register Free at http://www.pharmexec.com/liberating
Payer/Pharma Collaboration: A “Real World” Research Strategy for Aligning R&D to Evidence-based Healthcare
Recorded on: December 13, 2012
As physicians shift to evidence-based care, biopharma firms will need to provide the proof their medicines work in a range of real world scenarios. Are you ready? AT&T brings the insight of HealthCore, WellPoint’s research subsidiary with a “real world evidence” collaborative research program that uncovers missing information needed for care decisions. Learn about the formation of real world evidence and the new tools that allow payers and providers to accelerate R&D and clinical trial collaboration.
Register Free at http://www.pharmexec.com/aligning
Pharma 2020: From vision to decision
Recorded on: December 6, 2012
PwC’s newest report Pharma 2020: From vision to decision discusses the challenges facing the industry at this critical juncture in time and what companies must do to succeed over the next decade and beyond.
Register Free at http://www.pharmexec.com/decision
Price Waterhouse Coopers
Healthcare Reform Post Election Implications for Patient Access
Recorded on: December 5, 2012
This webinar tackles the post-election key implications of healthcare reform and how states plan to address the Affordable Care Act. It’s important to note that while 60 provisions of the ACA have already been implemented many of the remaining provisions will have the greatest impact on Patients Assistance Programs. Please join us on December 5th to learn more about this hot topic and its far-reaching impact.
Register Free at http://www.pharmexec.com/postelection
UBC Express Scripts
Mixed Methods, Rasch Modeling and Content Validity in the Development of Patient-reported Outcomes
Recorded on: December 4, 2012
The purpose of this webinar is to discuss the use of mixed methods, in particular Rasch modeling, during the early stages of PRO instrument development. Empirical evidence as to the appropriateness of small-sample Rasch modeling will be presented along with a discussion of many important scientific and practical considerations relevant to the issue.
Register Free at http://www.pharmexec.com/raschmodeling
Adopting a Pragmatic Approach to Compliance: Proactively Managing Aggregate Spend Data for Disclosure and Transparency Reporting
Recorded on: November 28, 2012
Join Greg Maynard as he describes the challenges and processes for implementing a spend management hub that consolidates, validates, corrects, categorizes, tracks, and certifies all spend records for an organization. The result is a cleansed and approved set of expenses for input into a transparency and aggregate spend reporting tool.
Register Free at http://www.pharmexec.com/spenddata
Health Market Science
Next Generation Informatics Needs for Pharma
Recorded: November 15, 2012
Join Paul McKenzie, VP of Manufacturing and Technical Operations from Janssen, and learn how a holistic approach to data management in product/process R&D and QC in commercial operations can improve operational efficiencies, reduce costs, enable QbD initiatives and significantly reduce compliance risks from lab to plant.
Register Free at http://www.pharmexec.com/informatics
Engaging Oncology Providers: What Works?
Recorded: November 14, 2012
In the rapidly evolving healthcare environment, engaging providers for successful collaboration is a key part of oncology commercialization strategy. Join Sandy Smith and Pete Perron as they discuss the key factors of provider engagement and how it affects you.
Register Free at http://www.pharmexec.com/whatworks
Brand: Going Beyond Single-Mindedness
Recorded on: November 8, 2012
Reimagine your brand going beyond mass market, while engaging customers singularly. Join us for Going Beyond the Single-Minded Proposition, a discussion led by Anne Stroup and Anthony Rotolo from TRUE Health + Wellness.
Register Free at http://www.pharmexec.com/single
TRUE Health + Wellness
Is Your Social Footprint Green or Red When it Comes to Risk?
Recorded: November 5, 2012
Want to recruit patients using social media? Use social media for marketing efforts? Leverage social media to shorten the development cycle? Now you can convince your legal and compliance departments it’s safe to go social!
Register Free at http://www.pharmexec.com/footprint
Exploratory Data Analysis - Getting More Out of Experimental and Observational Data
Recorded on: October 31, 2012
One of the biggest expenses faced by the pharmaceutical industry is collecting data needed to obtain registration and reimbursement. In the majority of cases, however, the use of these data is limited to providing results that are required for regulatory or reimbursement submissions. In the era of increased evidence burden, exploring data sources that are already available for further research is no longer just an option but a necessity. The webinar will focus on practical guidance on how to determine in which circumstances exploratory data analyses should be pursued as well as presentation of case studies.
Register Free at http://www.pharmexec.com/exploratory
Collaborate to Identify Risk & Improve Patient Engagement for Better Outcomes
Recorded on: October 30, 2012
Join leaders from the University of North Carolina at Chapel Hill School of Medicine, Health Innovation Partners and SAS Center for Health Analytics and Insights to hear strategies for a new approach to align care to improve patient outcomes and decrease the total cost of care.
Register Free at http://www.pharmexec.com/collaborativepartnerships
The Path to Agile Brand Management
Recorded on: October 25, 2012
Today’s Life Sciences landscape has no room for the “Slowskys”. Learn how to enable agile brand management and build the capabilities that lead to premium brand performance.
Register Free at http://www.pharmexec.com/agile
Measuring the Impact of e-Prescribing on Practicioner Behavior and Promotional Effectiveness
Recorded on: October 25, 2012
This session will support pharmaceutical sales and marketing leaders in making decisions on how to adapt and optimize commercial strategies and tactics to support the new prescribing environment including:
How does e-prescribing point-of-care information on preferred formulary products and cost of medication impact practitioner selection of the brand?
Does e-prescribing improve the likelihood that the patient will start and stay on the medication?
How should brand strategy or promotional tactics be adjusted based on a practioner’s e-prescribing behavior?
Register Free at http://www.pharmexec.com/eprescribing
Source Healthcare Analytics
Time and Motion Studies: What are They? Why are They Useful? What are the Challenges?
Recorded on: Tuesday, October 23, 2012
How could efficiency-related outcomes associated with products that improve process flow be measured? This webinar will address what Time and Motion studies are and how they can achieve this goal, as well as outline key design and operational challenges that must be identified and resolved to guarantee a scientifically robust study that is feasible to implement. This webinar will conclude with some practical examples of how outputs from a Time and Motion study can be used as inputs to other studies that generate value messages in support of launch and commercialization of a new biopharmaceutical or medical device product.
Register Free at http://www.pharmexec.com/timeandmotion
The Growing Role of the Patient in Cancer Treatment Selection
Recorded on: October 17, 2012
With growing access to information and increasing participation into their cancer care, patients are exercising greater influence over their treatment selection. Join Susan McClure and Dan Lodder as they discuss the evolving patient engagement strategies and the roles that print and digital media should play to fully take advantage of the opportunities.
Register Free at http://www.pharmexec.com/growing
Establishing a Foundation of Evidence for Successful Market Access: Phase I through Post-approval
Recorded on: September 19, 2012
New evidence demands have pushed pharmaceutical companies to adjust their internal structures to coordinate the generation of appropriate evidence. This webinar will address the internal and external opportunities for manufacturers to establish a foundation of evidence for successful market access, starting in Phase I of development and continuing throughout the post-approval product lifecycle.
Register Free at http://www.pharmexec.com/phase1
Clinical Trial Simulation: A Role for Facilitating Early Economic Analysis?
Recorded on: September 12, 2012
Should the lack of clinical efficacy data continue to prevent robust early economic evaluations of new drugs in development? Recent advances in clinical trial simulation strategies can provide information required to inform early economic models, enabling such models to be created prior to the availability of late stage clinical trial data.
Register Free at http://www.pharmexec.com/economic
The Impact of Comparative Effectiveness Research on the Healthcare Community
Recorded on: August 30. 2012
What is the impact of comparative effectiveness research (CER) on today’s healthcare environment? Join Dr. Rahul Dhanda as he discusses CER and how that impact might affect you.
Register Free at http://www.pharmexec.com/comparative
Sales Mobility: Where's the ROI?
Recorded on: Wednesday, July 18, 2012
In this webinar, we’ll dissect survey results by Aberdeen Research on the effectiveness of sales mobility strategies across 250 companies, see how “Best in Class” companies are proving the ROI of sales mobility, and discuss how keeping your mobile strategy “rep-centric” yields the quickest wins and best results.
Register Free at http://www.pharmexec.com/salesmobility
A Writer's Perspective on the Wrangling of Safety Documents ? Coordination and Integration across Multiple Requirements
Recorded on: Tuesday, July 17, 2012
Medical writers? approaches to authoring pre- and post-marketing safety documents will be discussed with emphasis on meeting multiple, international requirements for products at various stages of development.
Register Free at http://www.pharmexec.com/writers
Leveraging Social Media Communities for Compliant Collaboration for Specialty Key Opinion Leaders
Recorded On: Tuesday June 27, 2012
Who's afraid of social compliance?
Go social. Be compliant.
Register Free at www.pharmexec.com/socialmedia
Eliciting Patient-Centered Outcomes: Determining the Relative Strengths, Opportunities and Challenges of 6 Common Research Designs
Recorded On: Thursday, June 21, 2012
The Patient-Centered Outcomes Research Institute (PCORI) was created through the Affordable Care Act to improve health-care decision-making by patients, clinicians, payers and policy-makers by advancing the quality and relevance of evidence about disease prevention, diagnosis, treatment, and management. As part of its mandate, PCORI seeks to evaluate and improve methods for patient-centered outcomes research (PCOR). This webinar will discuss 6 research designs (RCTs, pragmatic trials, Bayesian adaptive trials, prospective observational studies, database studies, systematic evidence reviews) expected to be used and be useful in PCOR and the relative strengths, challenges and opportunities of each. Feedback will be elicited from participants on ways to improve each design to maximize its effectiveness to investigate heterogeneity of treatment effects and incorporate patient-reported outcomes (PROs).
Register Free at http://pharmexec.com/pcori
The Basics of the Sunshine Act and the Implications for Your Business
Recorded on: June 12, 2012
In this webcast Joe Marttila of Revitas and Mark Linver of Huron Consulting will explore the foundational importance of managing contracts with HCP/Os for full compliance with the Physician Payment Sunshine Act. They will examine the destructive impact of ?rogue contracting? and will outline best practices for managing agreement milestones and achieving deep insight into contract performance.
Register Free at http://www.pharmexec.com/basics
Creating Value in Contract Management Data Growth
Recorded on: June 7, 2012
Big data has big implications for contract lifecycle management. In this session, Joe Marttila and Rob Patterson of Revitas will discuss the biggest challenges facing companies in the management of excess internal and external data within their contract and revenue management systems. Join them to learn about best practices for how to turn this data into actionable insights for your business while enhancing system performance.
Register Free at www.pharmexec.com/value
Break Through the Barriers to Better Oncology Targeting with Medical Claims Data
Recorded on: June 5, 2012
Join Dilip Rajagopalan, senior director, Analytics at Health Market Science, as he demonstrates several approaches to drive commercial success in the largely non-retail world of oncology therapeutics. With case studies using medical claims, he’ll show improved methodologies for targeting oncologists and recruiting key opinion leaders.
Register Free at http://www.pharmexec.com/barriers
Health Market Science
Get Over It: Embrace Payer Expectations by Introducing Them Early in Product Development
Recorded on: May 2, 2012
Maximize your product's positioning and gain the competitive advantage in the market by addressing - and actually embracing - payer expectations early in product development. Important decisions that impact on market access are made very early in the development process, and with the increasing importance of the payer as stakeholder, companies now need to consider payer needs much earlier in their planning to ensure their product?s ultimate success.
Register Free at www.pharmexec.com/payer
Gain a Competitive Advantage with the Right Key Opinion Leaders: Leverage Social-Mobile Compliant Solutions to Identify and Manage Critical Business Collaborations with Thought leaders Your Competition Isn't Even Aware Of.
Recorded on: May 10, 2012
Are you sure your KOL Management Strategy and and data stand up to increased scrutiny? Are you confident you are collaborating with the right KOLs? Are you ready to safeguard your organization when using social and mobile media when engaging with HCPs?
If you answered 'Yes' to any of these questions, then this Webinar is for you.
Register Free at http://www.pharmexec.com/compliant
Otavio Freire, CTO, Open Q
Improving Efficiency through Process Transformation
Recorded on: May 17, 2012
Pharmaceuticals are threatened by rapidly changing demands. Join us for this webinar and learn how Pfizer is leading the way in achieving new levels of agility and growth through Process Excellence.
Register Free at http://www.pharmexec.com/software
NEED TO COMPLIANTLY ENGAGE KOLS, CONSULTANTS AND RESEARCHERS WITHOUT INCREASING YOUR BUDGET?
There's an App for that!
Recorded on: April 25, 2012
All mobile is not created equal - how do you know what's right for your organization and what will keep your assets safe?
Register Free at www.pharmexec.com/complianceseries
Matt Prentis, VP - Product Management, OpenQ, Inc.
DATA FOR COMPLIANCE
Are you Confident that your KOL Data will Stand Up to Scrutiny?
Recorded on: April 18, 2012
Can you confidently answer yes to this question: Does your KOL data stand up to scrutiny?
Register Free at www.pharmexec.com/complianceseries
Dr. R. Michael Broad, Medical Director, Open Q
Emily C. Whipple, PhD, Associate Medical Director, OpenQ
Utilization of Rasch Measurement Models for Assessing Validity: A Mixed Methods Approach
Recorded on: March 14, 2012
Development of reliable and valid patient or clinician reported outcome measures (PROs and ClinROs, respectively) requires a deep understanding of the patient population but also of the underlying latent traits of symptomology and disease impact or quality of life. Modern psychometric theory as opposed to complete reliance on classical test theory approaches including Rasch measurement models have been increasingly used in the development and refinement of PRO measures and have publicly been endorsed by the FDA. Rasch analysis can be implemented iteratively during instrument development as well as psychometric evaluation to fully understand the content and construct validity of PRO measures prior to use in Phase III trials.
Register Free at http://pharmexec.com/rasch
The Basics of the Sunshine Act and the Implications for Your Business
Recorded On: February 23, 2012
Over the last two years, most manufacturers have implemented reporting systems that will pull data from their existing source systems to create their Transparency Reports. Many companies have not created full end-to-end solutions to resolve the new Healthcare Reform laws. Many still use a manual approach to conquer the challenges of identifying, collecting, aggregating, and reporting transparency data. Others have chosen to invest in systems and revamp business processes by implementing reporting solutions to aggregate and report. Throughout 2011, many manufacturers gave priority to implementing Spend Reporting Applications (Engines), in order to meet the January 1, 2012 data collection milestone, without addressing issues identified in the "up-stream" processes across the Transparency Reporting Continuum. Since CMS has delayed the requirements to collect the spend information (required in section 1128G) manufacturers have been given the opportunity to either ?catch up? in their implementation efforts and/or address up-stream issues that may result in compliance gaps.
Register Free at http://pharmexec.com/sunshine
Meeting Global Patient Demand for Access to Medicines Prior to Approval and Launch
Wednesday, February 29, 2012 - 1:00 PM EST
Patients are more educated and empowered with regard to their health than ever before. Coupled with greater transparency of drug pipelines, patients with unmet medical needs, their advocates and physicians are increasingly and aggressively seeking access to drugs via alternative routes rather than waiting for the traditional process of approval to run its course.
To meet this demand, companies can use Managed Access Programs to provide global, pre-approval access to their innovative medicines, in full compliance with regulatory authorities.
Managed Access Programs encompass a variety of regulatory approaches that enable access to medicines that are not available to patients for a number of reasons including those drugs that:
• Are still in clinical development
• May never be approved, but still have medicinal value for a small population (for example, some orphan drugs)
• Are approved in one country, but not another
• Have been discontinued in a particular market
This webinar will present an overview of Managed Access Programs, how they can be leveraged to meet global patient demand, and the benefits afforded all stakeholders.
The session will also offer the patient advocacy perspective on the need for innovative routes to access and discuss how patients typically become aware of and navigate different access options, a particular challenge if treatments are not commercially available. The discussion will highlight strategies for establishing partnerships with patient groups to help facilitate a successful Managed Access Program.
Register Free at http://pharmexec.com/demand